Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I have not had time to catch up

The only thing I can come up with is that PTSC is negotiating a merger or aquisition and needs all the cash available for the deal. No dividends and no share buy back during this time. This may also explain the quiet period that we seem to be in since the settlement. I guess I'm speculating that there may be more to this quiet period than just the settlement with the J's IMO.

All the best,

Steve

Share
New Message
Please login to post a reply